根据一份提交给美国证券交易委员会(SEC)的文件,投资机构Shah资本管理公司表示,将在诺瓦瓦克斯医药于6月18日举行的股东投票中,对全部五项提案投出反对票。
根据一份提交给美国证券交易委员会(SEC)的文件,投资机构Shah资本管理公司表示,将在诺瓦瓦克斯医药于6月18日举行的股东投票中,对全部五项提案投出反对票。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.